(MedPage Today) -- Rituximab (Rituxan) paired with methotrexate slowed joint damage progression in patients with rheumatoid arthritis regardless of the level of disease activity, Austrian researchers reported. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment